For one of the C2 hubs, URGCP, previous findings indicate that its upregulation and downregulation are significantly involved in the molecular mechanisms of non-small cell lung cancer Cai et al. (2015); Consortium (2021). This evidence concerns the gene URGCP and non-small cell lung carcinoma.